Provided by Tiger Trade Technology Pte. Ltd.

Krystal Biotech Inc.

335.36
-4.6700-1.37%
Volume:91.77K
Turnover:30.71M
Market Cap:9.93B
PE:42.10
High:339.01
Open:339.01
Low:331.79
Close:340.03
52wk High:382.54
52wk Low:151.88
Shares:29.60M
Float Shares:23.54M
Volume Ratio:0.56
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.97
EPS(LYR):6.84
ROE:20.12%
ROA:9.37%
PB:7.30
PE(LYR):49.03

Loading ...

Stock Track | Krystal Biotech Plummets 5.27% Intraday Despite Q1 Earnings Beat as Analysts Cut Estimates

Stock Track
·
May 04

Krystal Biotech Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 04

Top Premarket Gainers

MT Newswires Live
·
May 04

S&P 500 Futures Fall In Premarket Trading; Victory Capital, Black Hills Lag

Dow Jones
·
May 04

Krystal Biotech Q1 revenue rises 32% on VYJUVEK growth

Reuters
·
May 04

Earnings Flash (KRYS) Krystal Biotech Posts Q1 EPS $1.83, vs. FactSet Est of $1.44

MT Newswires Live
·
May 04

Krystal Biotech 1Q26 net income climbs 56.58% to $55.9 million; revenue rises 32% to $116.4 million

Reuters
·
May 04

Stock Track | Krystal Biotech Soars 5.25% in Pre-Market on Strong Q1 Earnings and FDA RMAT Designation

Stock Track
·
May 04

BRIEF-Krystal Biotech Q1 Net Income USD 55.932 Million

Reuters
·
May 04

Krystal Biotech Announces First Quarter 2026 Financial and Operating Results

THOMSON REUTERS
·
May 04

Krystal Biotech Q1 Operating Expenses USD 62.668 Million

THOMSON REUTERS
·
May 04

Krystal Biotech Q1 EPS USD 1.83

THOMSON REUTERS
·
May 04

Krystal Biotech Inc - on Track for KB803 and KB801 (Nk) Registrational Data Readouts in 2026

THOMSON REUTERS
·
May 04

What Krystal Biotech (KRYS)'s RMAT Win for KB707 in Lung Cancer Means For Shareholders

Simply Wall St.
·
May 04

Krystal Biotech presents at ASGCT annual meeting

Reuters
·
Apr 30

High Growth Tech Stocks To Watch In The US April 2026

Simply Wall St.
·
Apr 30

TD Cowen Sticks to Their Buy Rating for Krystal Biotech (KRYS)

TIPRANKS
·
Apr 24

Krystal Biotech (KRYS) Valuation Check As Shares Trade Near Suggested 5.2% Discount To Fair Value

Simply Wall St.
·
Apr 23

Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026

GlobeNewswire
·
Apr 21

Krystal Biotech announces annual shareholder meeting notice, releases proxy statement

Reuters
·
Apr 04